In the past funding period, the Biostatistics Core has provided statistical support for the Projects, assisted inthe design of new studies and projects, and worked with the InterSPORE Bioinformatics Committee on thedefinition of common data elements related to the SPOREs and on the construction of a common OvarianSPORE tissue data base. The Core will continue these activities in the in the new proposal.
The specific aims of the Biostatistics Core are:
Aim 1) To provide the statistics and data analysis requiredby the projects and cores to achieve their specific aims. The Core will provide expertise and computationalfacilities to perform the statistical analyses required by each Project.
Aim 2) To assist in the design andimplementation of new trials and studies arising from the ongoing research of the SPORE. As progress ismade in each Project, new experiments and trials will be developed. The Biostatistics Core will lead thedesign of such proposed trials. If ongoing studies need to be modified, the Core will participate in theredesign to insure that the statistical properties of the trial are maintained.
Aim 3) To provide guidance tothe projects and cores in data management issues such as data entry and retrieval, quality assurance,security, and data backups. All the investigators involved in the SPORE have experience with the softwarerequired to enter, maintain, and retrieve the data produced by their Projects. As necessary, the Core willprovide assistance in the data management of each project. The Core will provide expertise in the selectionof software and in data design, audit, and backup.
Aim 4) To facilitate the exchange of information and databetween the components of the SPORE by providing assistance in networking, email, data translation, andelectronic file exchange. Success of the SPORE depends upon a close cooperation among the Projects andCores. The Biostatistics Core will facilitate the exchange of data and information between Projects. The Corewill assist in electronic transfer and in the selection of data items and format to ensure data compatibility.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Specialized Center (P50)
Project #
5P50CA083639-09
Application #
7729378
Study Section
Special Emphasis Panel (ZCA1-GRB-I (O1))
Project Start
2008-09-04
Project End
2010-08-31
Budget Start
2008-09-04
Budget End
2009-08-31
Support Year
9
Fiscal Year
2008
Total Cost
$124,752
Indirect Cost
Name
University of Texas MD Anderson Cancer Center
Department
Type
DUNS #
800772139
City
Houston
State
TX
Country
United States
Zip Code
77030
Rhyasen, Garrett W; Yao, Yi; Zhang, Jingwen et al. (2018) BRD4 amplification facilitates an oncogenic gene expression program in high-grade serous ovarian cancer and confers sensitivity to BET inhibitors. PLoS One 13:e0200826
Chen, Jian; Zaidi, Sobia; Rao, Shuyun et al. (2018) Analysis of Genomes and Transcriptomes of Hepatocellular Carcinomas Identifies Mutations and Gene Expression Changes in the Transforming Growth Factor-? Pathway. Gastroenterology 154:195-210
Sun, Chaoyang; Yin, Jun; Fang, Yong et al. (2018) BRD4 Inhibition Is Synthetic Lethal with PARP Inhibitors through the Induction of Homologous Recombination Deficiency. Cancer Cell 33:401-416.e8
Hu, Xiaowen; Sood, Anil K; Dang, Chi V et al. (2018) The role of long noncoding RNAs in cancer: the dark matter matters. Curr Opin Genet Dev 48:8-15
Jung, Youn-Sang; Wang, Wenqi; Jun, Sohee et al. (2018) Deregulation of CRAD-controlled cytoskeleton initiates mucinous colorectal cancer via ?-catenin. Nat Cell Biol 20:1303-1314
Jung, Youn-Sang; Jun, Sohee; Kim, Moon Jong et al. (2018) TMEM9 promotes intestinal tumorigenesis through vacuolar-ATPase-activated Wnt/?-catenin signalling. Nat Cell Biol 20:1421-1433
Nagaraja, Archana S; Dood, Robert L; Armaiz-Pena, Guillermo et al. (2018) Adrenergic-mediated increases in INHBA drive CAF phenotype and collagens. JCI Insight 3:
Seo, Hyeonglim; Choi, Ikjang; Whiting, Nicholas et al. (2018) Hyperpolarized Porous Silicon Nanoparticles: Potential Theragnostic Material for 29 Si Magnetic Resonance Imaging. Chemphyschem 19:2143-2147
Mitamura, T; Pradeep, S; McGuire, M et al. (2018) Induction of anti-VEGF therapy resistance by upregulated expression of microseminoprotein (MSMP). Oncogene 37:722-731
Yuan, Jiao; Hu, Zhongyi; Mahal, Brandon A et al. (2018) Integrated Analysis of Genetic Ancestry and Genomic Alterations across Cancers. Cancer Cell 34:549-560.e9

Showing the most recent 10 out of 648 publications